HC Wainwright Issues Pessimistic Forecast for CGTX Earnings
Cognition Therapeutics, Inc. (NASDAQ:CGTX – Free Report) – Analysts at HC Wainwright reduced their Q1 2025 earnings estimates for shares of Cognition Therapeutics in a note issued to investors on Monday, March 24th. HC Wainwright analyst R. Selvaraju now expects that the company will earn ($0.12) per share for the quarter, down from their previous […]
Cognition Therapeutics, Inc. (NASDAQ:CGTX – Free Report) – Analysts at HC Wainwright reduced their Q1 2025 earnings estimates for shares of Cognition Therapeutics in a note issued to investors on Monday, March 24th. HC Wainwright analyst R. Selvaraju now expects that the company will earn ($0.12) per share for the quarter, down from their previous […]
